Following the publication of Radford’s Q4 2019 Workforce Trends Report for life sciences companies, our team took a deep dive into hiring plans and turnover rates at U.S.-based firms, segmenting the data by the pre-commercial and commercial stages of development. As of Q4, overall turnover is down more than 3% among pre-commercial companies. At commercial companies turnover is relatively unchanged from Q3, though we are seeing a significant uptick in the prevalence of companies shifting to selective hiring plans as they hit the brakes on headcount growth.